SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,631. The last known price of Bitcoin is 68,229.80907922 USD and is down -4.02 over the last 24 hours. It is currently trading on 12780 active market(s) with $42,739,134,877.94 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and reports of heavy leveraged-position liquidations are driving the conversation, with traders debating whether the move marks capitulation or signals more downside. Some see a buying opportunity and expect a bounce, while others cite weak support and fear of further crypto-market losses.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.0099454 USD and is down -2.36 over the last 24 hours. It is currently trading on 1896 active market(s) with $2,532,309,467.05 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is drawing attention after a sharp slide alongside Bitcoin and the broader crypto market, with traders pointing to market-wide selling rather than a confirmed XRP-specific catalyst. The break below a key psychological level has fueled fears of further losses, while other traders see an oversold dip and are accumulating.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,738,272,860.16806072. The last known price of Dogecoin is 0.06457313 USD and is down -2.71 over the last 24 hours. It is currently trading on 1545 active market(s) with $672,498,596.98 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a steep selloff alongside the broader crypto market, with traders pointing to prolonged weakness and fresh lows. The conversation is largely bearish, with fears of further declines competing with dip-buying and calls to hold for a recovery.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,215,668.80579185. The last known price of Ethereum is 1,929.81008702 USD and is down -4.05 over the last 24 hours. It is currently trading on 14342 active market(s) with $15,325,408,368.61 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is caught in a broad crypto selloff, with traders citing Bitcoin weakness and forced liquidations alongside wider risk-off pressure and macro concerns. Sentiment is split between calls that the decline may be capitulation and expectations of further losses, while some traders are buying the dip.

Hedera (HBAR) is a cryptocurrency launched in 2017. Hedera has a current supply of 50,000,000,000 with 44,327,140,678.86417527 in circulation. The last known price of Hedera is 0.06118377 USD and is down -3.83 over the last 24 hours. It is currently trading on 468 active market(s) with $73,346,897.90 traded over the last 24 hours. More information can be found at https://www.hedera.com/.

Hedera Hashgraph

HBAR is drawing attention after traders linked its sharp rally to Nvidias involvement in the Hedera Council and Hederas presence in Nvidias Open Agent Safety Platform. The community is split between viewing the AI association as a meaningful catalyst and calling the move hype or a sell-the-news pump as the token pulls back.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,964,197.93006099. The last known price of Zcash is 932.62986485 USD and is down -2.50 over the last 24 hours. It is currently trading on 670 active market(s) with $1,142,095,783.67 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcash is drawing attention amid a steep pullback from recent highs, with traders discussing weakening support, possible liquidations and broader crypto-market pressure. The community is split between calling the drop an oversold buying opportunity and expecting more downside; some also point to Zcashs privacy features and network upgrades as reasons for longer-term optimism.

Cardano (ADA) is a cryptocurrency launched in 2017. Cardano has a current supply of 44,994,648,344.194204 with 36,816,370,531.313927 in circulation. The last known price of Cardano is 0.16792499 USD and is down -4.07 over the last 24 hours. It is currently trading on 1752 active market(s) with $304,416,326.91 traded over the last 24 hours. More information can be found at https://www.cardano.org.

Cardano

Cardanos steep selloff is driving widespread bearish frustration, with some traders tying the loss of confidence to Charles Hoskinsons statement that the networks roadmap is complete and future progress depends on community governance and applications. Others are buying the dip and anticipating a rebound, leaving the conversation split between fears of further losses and hopes for recovery.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 637,493,507.45679271 with 591,519,914.8768357 in circulation. The last known price of Solana is 77.75210106 USD and is down -4.52 over the last 24 hours. It is currently trading on 1189 active market(s) with $3,771,510,230.13 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solana is drawing attention amid a sharp broader crypto selloff, with traders noting heavy downside pressure and a break below a closely watched support area as Bitcoin and other major tokens also fall. The community is split between buying the dip and expecting further declines, with some attributing the weakness to political or security concerns but no single explanation emerging as consensus.

Quant (QNT) is a cryptocurrency and operates on the Ethereum platform. Quant has a current supply of 14,881,364 with 12,072,738 in circulation. The last known price of Quant is 159.21664083 USD and is down -1.76 over the last 24 hours. It is currently trading on 414 active market(s) with $110,625,382.40 traded over the last 24 hours. More information can be found at https://quant.network/.

Quant

Quant is drawing attention after a steep selloff alongside broader crypto weakness, with traders debating whether the pullback has further to run or is a buying opportunity. Many are accumulating on weakness based on the long-term tokenized-banking and Clearing House thesis, while skeptics question the tokens near-term demand before the network goes live.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,407,571,868.045494 in circulation. The last known price of Stellar is 0.14587805 USD and is down -1.99 over the last 24 hours. It is currently trading on 848 active market(s) with $216,910,874.56 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLM is drawing attention for a sharp slide amid broader crypto weakness, with traders focused on persistent selling and its failure to hold recent levels. Bearish posts call it a continuing breakdown, while others are buying the dip and arguing that Stellars tokenization and DTCC-related prospects may support the longer-term case despite muted price action.

statis crypto Watchlist

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Belite Bio (BLTE) Q3 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Belite Bio To Present Tinlarebant Data At Euretina

(RTTNews) - Tuesday, Belite Bio (BLTE) said it will present data from its retinal disease programs at two upcoming medical conferences in Vienna, including topline Phase 3 DRAGON study results for tinlarebant in adolescent Stargardt disease...

Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

Belite Bio Announces NDA Submission In Japan For Tinlarebant Under Sakigake Designation

(RTTNews) - Belite Bio (BLTE) announced the submission of a New Drug Application to the Ministry of Health, Labour, and Welfare in Japan for tinlarebant in Stargardt disease type 1. Tinlarebant has been designated a SAKIGAKE pharmaceutical product for accelerated review and the N...

Why Is Belite Bio Stock Soaring Friday?

Canaccord Genuity initiates Belite Bio (BLTE) with a Buy and $303 target on FDA Priority Review for tinlarebant.read more...

BLTE Stock Rises as FDA Grants Priority Review to Tinlarebant NDA

Belite Bio's tinlarebant wins FDA priority review for Stargardt Disease, with a decision expected in February 2027 after positive phase III data.

CoreWeave To Rally Around 95%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts change outlook on top names. HC Wainwright raises price target for Belite Bio, while B of A cuts Lumentum's target.read more...

Why Is Belite Bio Stock Gaining Monday?

Belite Bio (BLTE) stock jumps 3% on positive Phase 3 DRAGON trial data for its Stargardt disease drug candidate tinlarebant.read more...

Full Transcript: Belite Bio Q1 2026 Earnings Call

Belite Bio Enters Oversold Territory (BLTE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

$BLTE Q3 &#39;26 Earnings Results &amp; Recap

Reported GAAP EPS of -$0.60 down -130.77% YoY

Stocktwits

Belite Bio Inc

 Q3 '26 Earnings Results & Recap

Reported GAAP EPS of -$0.60 down -130.77% YoY

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Reported GAAP EPS of -$0.60 down -130.77% YoY

Belite Bio's Q3 expenses were higher than Q3 2025 levels, its net loss was higher than in Q3 2025, and PHOENIX results may not support regulatory approval; FDA review is still ongoing.

Belite Bio's DRAGON trial met its primary endpoint, with a 35.7% reduction in retinal-lesion growth versus placebo; tinlarebant received FDA Priority Review and Japan's Sakigake designation.

Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.

Belite Bio Inc - ADR

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

BLTE News